Pantheris™ First-Ever Image-Guided Atherectomy Device Designed to Empower Physicians to Precisely Remove Plaque While Avoiding Disruption of Healthy Arteries
Deborah is the first hospital in New Jersey to offer a new treatment recently cleared by the U.S. Food and Drug Administration (FDA) to provide relief for patients suffering from the painful symptoms of peripheral artery disease, or PAD – a condition caused by a build-up of plaque that blocks blood flow in the arteries of legs or feet.
The device, Avinger’s Pantheris™ lumivascular atherectomy system, is an innovative image-guided therapy which, for the first time ever, allows physicians to see and remove plaque simultaneously during atherectomy – a minimally invasive procedure that involves cutting plaque away from the artery and clearing it out to restore blood flow.
Because the Pantheris device incorporates real-time optical coherence tomography (OCT) imaging on a therapeutic catheter – like having a small camera on the tip of the device – physicians are able to remove this plaque more precisely than ever before. With less risk of damage to the artery walls – which can result in aggressive scarring – there is greatly reduced risk of restenosis, or re-narrowing of the artery. In the past, physicians have had to rely solely on X-ray, as well as touch and feel, to guide their tools while they treated complicated arterial disease.
For patients, this safe and more-precise treatment may potentially reduce the need for follow-up procedures and stents.